MARATTO

article · Health Science Reports

Safety and Efficacy of Nephron‐Sparing Surgery in Bilateral Wilms Tumors: A Systematic Review and Meta‐Analysis

2025Open accessSuez University

Abstract

Background and Aims: Bilateral Wilms tumor (BWT) presents a significant challenge in pediatric oncology, necessitating a delicate balance between achieving oncological control and preserving renal function. While nephron-sparing surgery (NSS) has emerged as a promising alternative to radical nephrectomy, its overall safety and efficacy profile for BWT remains to be consolidated. This systematic review and meta-analysis aimed to synthesize the available evidence to evaluate the pooled safety and efficacy outcomes of NSS in children with BWT. Methods: Following PRISMA guidelines, a systematic search was conducted across five databases (PubMed, Medline, Web of Science, SCOPUS, Cochrane Library). We included studies reporting on pediatric patients with BWT treated with NSS. A single-arm meta-analysis was performed using a random-effects model to pool estimates for survival, recurrence, and renal function outcomes. Results: Thirteen studies comprising 749 patients were included. The pooled overall survival rate was 55.9% (95% CI: 38.2%-73.7%), relapse-free survival was 51.4% (95% CI: 32.6%-70.3%), and event-free survival was 38.0% (95% CI: 23.3%-52.7%). The recurrence rate was 14.9% (95% CI: 9.4%-20.5%). Critically, renal function was well-preserved, with a mean glomerular filtration rate (GFR) of 92.0 mL/min/1.73 m². The need for dialysis (1.7%) and renal transplantation (4.3%) was low. Conclusion: NSS provides a viable surgical strategy for BWT, effectively preserving renal function without unduly compromising survival outcomes. The acceptable recurrence and low renal replacement therapy rates underscore its role in mitigating long-term morbidity. Significant heterogeneity across studies highlights the need for standardized treatment protocols and prospective research to optimize patient selection and outcomes.

Research topics

  • Renal and related cancers
  • Tuberous Sclerosis Complex Research
  • Renal cell carcinoma treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/hsr2.71710

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.